59 results on '"Connolly S"'
Search Results
2. Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE‐LY trial
3. Supplement to: Andexanet alfa for the reversal of factor Xa inhibitor activity.
4. Who is at risk of death from nephrectomy? An analysis of thirty‐day mortality after 21 380 nephrectomies in 3 years of the British Association of Urological Surgeons (BAUS) National Nephrectomy Audit
5. Anti-NMDA-receptor antibody-mediated cortical blindness: a case report
6. Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European Dermatology Forum – Short version
7. NAVIGATE ESUS: Multicenter, Randomized, Double-Blind, Phase III Trial of Rivaroxaban vs. Aspirin for the Prevention of Recurrent Stroke and Systemic Embolism in Patients with Recent Embolic Stroke of Undetermined Source: O77
8. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV—a survey from the European Society of Cardiology
9. Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial
10. Good syndrome and lichen planus: case and review
11. Supplement to: Dabigatran versus warfarin in patients with mechanical heart valves
12. Supplement to: Dronedarone in high-risk permanent atrial fibrillation.
13. Supplement to: Apixaban in patients with atrial fibrillation.
14. Anal evoked potential (AEP) recordings: method validation and results in patients with faecal incontinence: PP107
15. Supplement to: Newly identified events in the RE-LY trial.
16. Supplement to: Dabigatran versus warfarin in patients with atrial fibrillation.
17. Pharmacoscintigraphy confirms consistent tamsulosin release from a novel triple-layered tablet
18. Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation
19. Poster session Friday 7 December - PM: Effect of systemic illnesses on the heart
20. Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin
21. Modulation of gastric pH by a buffered soluble effervescent formulation: A possible means of improving gastric tolerability of alendronate
22. Late-onset CMT phenotype caused by a novel mutation in the MPZ gene
23. Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation
24. Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: reply to a rebuttal
25. Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
26. Is simple nephrectomy truly simple? Comparison with the radical alternative
27. Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry
28. Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis
29. Multi-focal motor neuropathy due to infliximab: P1607
30. Does dabigatran improve stroke-prevention in atrial fibrillation? Reply to a rebuttal
31. Application of cardioprotective medication
32. Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study
33. EFFECTS OF STATIN ON MORTALITY AND APPROPRIATE SHOCKS IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR PATIENTS: A SYSTEMATIC REVIEW OF COHORT STUDIES: 7.5
34. Analysis of routine EEG usage in a general adult ICU
35. Do gastrointestinal transit parameters influence the pharmacokinetics of gefitinib?
36. Scintigraphic evaluation of colon targeting pectin–HPMC tablets in healthy volunteers
37. Artificial hydroureteronephrosis to facilitate MR urography during pregnancy
38. Is TURP a dying operation?: P21
39. A new mechanism for inhalational priming: IL-4 bypasses the need for innate immune signals: 146
40. Persistent lactic acidosis in neonatal hypoxic–ischaemic encephalopathy correlates with EEG grade and electrographic seizure burden
41. Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures
42. Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis
43. The regulation of dendritic cell function by calcium-signaling and its inhibition by microbial pathogens
44. Spasticity After Spinal Cord Injury: An Evidence-Based Review of Current Interventions
45. Enhancing Upper Extremity Function with Reconstructive Surgery in Persons with Tetraplegia: A Review of the Literature
46. Comparative study on the efficacy of pioglitazone in Caucasian and Maori–Polynesian patients with poorly controlled type 2 diabetes
47. NOVEL SYSTEM FOR AUTOMATED SEIZURE DETECTION IN NEWBORNS: 097
48. HEART RATE VARIABILITY IN NEONATES WITH SEIZURES: 099
49. EARLY CONTINUOUS VIDEO-EEG MONITORING AND PREDICTION OF NEURODEVELOPMENTAL OUTCOME IN MODERATE NEONATAL HYPOXIC-ISCHAEMIC ENCEPHALOPATHY: 067
50. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.